Mesoblast Limited - American Depositary Shares (NQ:MESO)

13.61 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mesoblast Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023 ↗

August 31, 2023

Via Benzinga

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs ↗

August 29, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 22, 2023

Via Benzinga

Why Shares of Mesoblast Are Down Monday ↗

August 07, 2023

The company's shares continued to tumble after it received a Complete Response Letter last week from the FDA.

Via The Motley Fool

Why Shares of Mesoblast Are Plunging Friday ↗

August 04, 2023

The company received a Complete Response Letter from the FDA regarding its prospective graft-versus-host disease therapy.

Via The Motley Fool

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023 ↗

August 07, 2023

Via Benzinga

Dow Turns Lower; Amazon Shares Jump After Strong Q2 Results ↗

August 04, 2023

U.S. stocks pared gains toward the end of trading, with the Dow Jones and S&P 500 turning lower on Friday. The Dow traded down 0.08% to 35,187.47 while the NASDAQ rose 0.18% to 13,984.31. The S&P 500,...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 04, 2023

On Friday, 73 companies reached new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 04, 2023

Via Benzinga

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Nasdaq Surges Over 100 Points; Apple Shares Fall After Q3 Results ↗

August 04, 2023

U.S. stocks were higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded up 0.50% to 35,390.90 while the NASDAQ rose 0.81% to 14,072.42. The S&P 500,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗

August 04, 2023

Via Benzinga

Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories ↗

August 04, 2023

Wall Street Journal

Via Benzinga

Dow Jumps Over 100 Points; US Nonfarm Payrolls Miss Expectations ↗

August 04, 2023

U.S. stocks were higher this morning, following the release of jobs data. Following the market opening Friday, the Dow traded up 0.39% to 35,351.48 while the NASDAQ rose 0.79% to 14,070.50. The S&P...

Via Benzinga

Mesoblast Shares Tumble As FDA Strikes Out Cell Therapy Application For Children Again, Requires Additional Trial ↗

August 04, 2023

The FDA issued a complete response letter to Mesoblast Limited's (NASDAQ: MESO) resubmission for remestemcel-L for pediatric steroid-refractory acute graft

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 28, 2023

Via Benzinga

Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion ↗

July 27, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 18, 2023

Via Benzinga

Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday ↗

July 13, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...

Via Benzinga

WD-40, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

July 11, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Hesai Group (NASDAQ: HSAI) rose 14.4% to $12.34.

Via Benzinga

BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities ↗

July 06, 2023

BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb

Via Benzinga

William Blair Initiates Mesoblast Soon After Its Lead Product Goes Under FDA Review In Pediatric Indication ↗

March 09, 2023

Via Benzinga

Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 08, 2023

Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 08, 2023

Via Benzinga

Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday ↗

March 08, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids ↗

March 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 08, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.